Attended AGM,ORH supplies to Mcmahon & Theiss, share purchase plan rounding up coming soon, 40million shares out of escrow soon.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling